GlassScriptPhysician profile
Yousuf Sayeed
NPI 1932155926
$13,267.95
in general payments reported to CMS, 2019-2025
29 companies · $2,651 in 2025
The $2,651 reported for 2025 was more than what 83% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,759 · 2020: $854 · 2021: $1,180 · 2022: $884 · 2023: $4,580 · 2024: $1,360 · 2025: $2,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,862 · Travel and Lodging: $2,279 · Consulting Fee: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,862.49 |
| Travel and Lodging | $2,278.63 |
| Consulting Fee | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $3,721.22 | 2023-2025 | Evoke Scs, Evoke |
| Abbott Laboratories | $2,386.98 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $1,189.71 | 2019-2025 | Superion Indirect Decompression System, General - Pain Management |
| Globus Medical, INC. | $994.15 | 2025 | Vyrsa V1, Senza |
| Medtronic, INC. | $871.27 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Biotronik Nro, INC. | $767.74 | 2023-2025 | Prospera, Biotronik |
| Nevro Corp. | $690.98 | 2019-2024 | Senza |
| Mml US, INC. | $509.67 | 2024-2025 | Reactiv8 |
| Medtronic USA, INC. | $383.88 | 2019-2020 | |
| Vertiflex, INC. | $237.02 | 2019 | |
| Stimwave Technologies Incorporated | $220.20 | 2019-2022 | |
| Spr Therapeutics, INC | $200.53 | 2023-2024 | Sprint Pns System |
| Stryker Corporation | $156.69 | 2025 | Optablate |
| Amgen INC. | $146.99 | 2024 | Evenity, Prolia |
| Abbvie INC. | $144.03 | 2023-2025 | Teflaro, Dalvance |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $117.00 | 2021 | |
| Si-Bone, INC. | $96.83 | 2021-2022 | |
| Spinal Simplicity, LLC | $93.50 | 2023-2025 | Ha Minuteman G3-R |
| Foundation Fusion Solutions, LLC | $75.92 | 2021 | |
| Vertos Medical, INC. | $63.49 | 2019 | |
| Tersera Therapeutics LLC | $33.04 | 2025 | Prialt |
| Curonix LLC | $30.62 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $24.31 | 2023 | Qutenza |
| Avanos Medical | $23.71 | 2024 | Generator |
| Nalu Medical, INC. | $22.27 | 2022 | |
| Valinor Pharma, LLC | $21.77 | 2025 | Movantik |
| Pfizer INC. | $17.56 | 2019 | |
| Relievant Medsystems, INC. | $13.65 | 2023 | Intracept |
| Arteriocyte Medical Systems, INC. | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yousuf Sayeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.